AHA 2012 schedule: Difference between revisions
No edit summary |
|||
(34 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
Here is the page we will use to coordinate the TV events at AHA 2012. Open time slots are indicated below in red. | Here is the page we will use to coordinate the TV events at AHA 2012. Open time slots are indicated below in red. | ||
Line 32: | Line 30: | ||
===2:30 PM=== | ===2:30 PM=== | ||
''2:30 PM – 3:00 PM'' | |||
*'''Interviewee:''' Dr. Evan Stein | |||
*'''Topic:''' Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects (GAUSS): Interim Results from a Randomized, Double-blind, Placebo-controlled Study | |||
*'''Embargo lift:''' Monday, November 5, 2012 | |||
===3:00 PM=== | ===3:00 PM=== | ||
Line 38: | Line 39: | ||
*'''Interviewee:''' Dr. Elizabeth A. Magnuson | *'''Interviewee:''' Dr. Elizabeth A. Magnuson | ||
*'''Topic:''' Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease: Results from the FREEDOM Trial | *'''Topic:''' Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease: Results from the FREEDOM Trial | ||
*'''Embargo lift:''' Sunday, November 4, 2012 | *'''Embargo lift:''' Sunday, November 4, 2012 at 6:12 PM | ||
===3:30 PM=== | ===3:30 PM=== | ||
''3:30 PM – 4:30 PM'' | |||
*'''Interviewee:''' Dr. Paul Gurbel and Dr. Magnus Ohman | |||
*'''Topic:''' First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial – The TRILOGY ACS Platelet Function Sub-study | |||
*'''Embargo lift:''' Sunday, November 4, 2012 | |||
===4:30 PM=== | ===4:30 PM=== | ||
''4:30 PM – 5:30 PM'' | |||
*'''Interviewee:''' Dr. Timothy Brighton | |||
*'''Topic:''' Aspirin for The Prevention of Recurrent Venous Thromboembolism After a First Unprovoked Event: Results of the ASPIRE Randomized Controlled Trial | |||
*'''Embargo lift:''' Sunday, November 4, 2012 | |||
Line 65: | Line 63: | ||
===9:00 AM=== | ===9:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
Line 83: | Line 69: | ||
===1:00 PM=== | ===1:00 PM=== | ||
''1:00 PM – 1:30 PM'' | |||
*'''Interviewee:''' Dr. Bradley A. Bart | |||
*'''Topic:''' Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Results of CARRESS-HF, for the Heart Failure Clinical Research Network | |||
*'''Embargo lift:''' Tuesday, November 6, 2012 at 5:13 PM | |||
===2:00 PM=== | ===2:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
=== | == Monday November 5, 2012== | ||
=== | ===7:30 AM=== | ||
''7:30 AM – 8:00 AM'' | |||
*'''Interviewee:''' Dr. Valentin Fuster | |||
*'''Topic:''' Main Results of the Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal management of Multivessel disease (FREEDOM) Trial | |||
*'''Embargo lift:''' Sunday, November 4, 2012 | |||
===8:00 AM=== | ===8:00 AM=== | ||
''8:00 AM – 8:30 AM'' | |||
*'''Interviewee:''' Dr. Stephen Wiviott | |||
*'''Topic:''' TRILOGY ACS Angiographic Cohort: A Prospective, Randomized Trial of Prasugrel vs. Clopidogrel in Patients with Non-ST-Segment Elevation ACS Who Are Medically Managed After Coronary Angiography | |||
===8:30 AM=== | ===8:30 AM=== | ||
''8:30 AM – 9:00 AM'' | |||
*'''Interviewee:''' Dr. Eric L. Eisenstein | |||
*'''Topic:''' Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery | |||
*'''Embargo lift:''' Sunday, November 4, 2012 | |||
===9:00 AM=== | ===9:00 AM=== | ||
Line 122: | Line 109: | ||
===10:30 AM=== | ===10:30 AM=== | ||
''10:30 AM – 11:00 AM'' | |||
*'''Interviewee:''' Dr. Daniel Sürder and Dr. Roberto Corti | |||
*'''Topic:''' Results of the Swiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction (Swiss AMI) Trial | |||
*'''Embargo lift:''' Tuesday, November 6, 2012 | |||
=== | ===11:00 AM=== | ||
'' | ''11:00 AM - 11:30 AM'' | ||
*'''Interviewee:''' Dr. Renato Lopes | *'''Interviewee:''' Dr. Renato Lopes | ||
*'''Topic:''' AHA Wrap-Up in Portuguese | *'''Topic:''' AHA Wrap-Up in Portuguese | ||
Line 135: | Line 125: | ||
===2:00 PM=== | ===2:00 PM=== | ||
''2:00 PM - 2:30 PM'' | |||
*'''Interviewee:''' Dr. Basil Lewis | |||
*'''Topic:''' AHA Wrap-Up in Hebrew | |||
===2:30 PM=== | ===2:30 PM=== | ||
Line 155: | Line 147: | ||
===4:00 PM=== | ===4:00 PM=== | ||
''4:00 PM – 4:30 PM'' | |||
*'''Interviewee:''' Dr. Howard D. Sesso | |||
*'''Topic:''' A Randomized Trial of a Multivitamin in the Prevention of Cardiovascular Disease in Men: The Physicians’ Health Study II | |||
*'''Embargo lift:''' Monday, November 5, 2012 | |||
===4:30 PM=== | ===4:30 PM=== | ||
''4:30 PM - 5:00 PM'' | |||
*'''Interviewee:''' Dr. Freek W.A. Verheugt, Dr. Jan Hein Cornel, and Dr. Ton Oude Ophuis | |||
*'''Topic:''' AHA Wrap-up from a Dutch Perspective | |||
===5:30 PM=== | ===5:30 PM=== | ||
''5:30 PM - 6:00 PM'' | |||
*'''Interviewee:''' Dr. Lars Wallentin | |||
*'''Topic:''' AHA Wrap-up from a Scandinavian Perspective | |||
== Tuesday November 6, 2012== | == Tuesday November 6, 2012== | ||
===8:30 AM=== | ===8:30 AM=== | ||
''8:30 AM - 9:00 AM'' | |||
*'''Interviewee:''' Dr. Paul Armstrong | |||
*'''Topic:''' AHA Wrap-Up from a Canadian Perspective | |||
===9:00 AM=== | ===9:00 AM=== | ||
''9:00 AM – 9:30 AM'' | |||
*'''Interviewee:''' Dr. Thomas R. Porter | |||
*'''Topic:''' Prospective Evaluation of Outcomes With Stress Perfusion Imaging Versus Stress Wall Motion Imaging During Dobutamine or Exercise Echocardiography | |||
*'''Embargo lift:''' Sunday, November 4, 2012 | |||
===9:30 AM=== | ===9:30 AM=== | ||
''9:30 AM – 10:00 AM'' | |||
*'''Interviewee:''' Dr. Gregory G. Schwartz | |||
*'''Topic:''' Effects of the Cholesteryl Ester Transfer Protein Inhibitor Dalcetrapib in Patients with Recent Acute Coronary Syndrome | |||
*'''Embargo lift:''' Monday, November 5, 2012 at 12:00 PM | |||
===10:00 AM=== | ===10:00 AM=== | ||
''10:00 AM – 10:30 AM'' | |||
*'''Interviewee:''' Dr. Frederick J. Raal | |||
*'''Topic:''' Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD): Interim Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial | |||
*'''Embargo lift:''' Monday, November 5, 2012 | |||
===1:00 PM=== | ===1:00 PM=== | ||
Line 199: | Line 196: | ||
===2:00 PM=== | ===2:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
Latest revision as of 18:25, 1 November 2012
Here is the page we will use to coordinate the TV events at AHA 2012. Open time slots are indicated below in red.
Filming location TBD.
Click on Date for Detailed Schedule
Saturday November 3, 2012
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
2:30 PM – 3:00 PM
- Interviewee: Dr. Evan Stein
- Topic: Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects (GAUSS): Interim Results from a Randomized, Double-blind, Placebo-controlled Study
- Embargo lift: Monday, November 5, 2012
3:00 PM
3:00 PM – 3:30 PM
- Interviewee: Dr. Elizabeth A. Magnuson
- Topic: Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease: Results from the FREEDOM Trial
- Embargo lift: Sunday, November 4, 2012 at 6:12 PM
3:30 PM
3:30 PM – 4:30 PM
- Interviewee: Dr. Paul Gurbel and Dr. Magnus Ohman
- Topic: First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial – The TRILOGY ACS Platelet Function Sub-study
- Embargo lift: Sunday, November 4, 2012
4:30 PM
4:30 PM – 5:30 PM
- Interviewee: Dr. Timothy Brighton
- Topic: Aspirin for The Prevention of Recurrent Venous Thromboembolism After a First Unprovoked Event: Results of the ASPIRE Randomized Controlled Trial
- Embargo lift: Sunday, November 4, 2012
Sunday November 4, 2012
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
1:00 PM
1:00 PM – 1:30 PM
- Interviewee: Dr. Bradley A. Bart
- Topic: Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Results of CARRESS-HF, for the Heart Failure Clinical Research Network
- Embargo lift: Tuesday, November 6, 2012 at 5:13 PM
2:00 PM
OPEN TIME SLOT
Monday November 5, 2012
7:30 AM
7:30 AM – 8:00 AM
- Interviewee: Dr. Valentin Fuster
- Topic: Main Results of the Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal management of Multivessel disease (FREEDOM) Trial
- Embargo lift: Sunday, November 4, 2012
8:00 AM
8:00 AM – 8:30 AM
- Interviewee: Dr. Stephen Wiviott
- Topic: TRILOGY ACS Angiographic Cohort: A Prospective, Randomized Trial of Prasugrel vs. Clopidogrel in Patients with Non-ST-Segment Elevation ACS Who Are Medically Managed After Coronary Angiography
8:30 AM
8:30 AM – 9:00 AM
- Interviewee: Dr. Eric L. Eisenstein
- Topic: Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery
- Embargo lift: Sunday, November 4, 2012
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
10:00 AM – 10:30 AM
- Interviewee: Dr. Jay H. Traverse
- Topic: The Effect of Timing of Stem Cell Delivery Following Acute Myocardial Infarction: The NHLBI and CCTRN TIME Trial
- Embargo lift: Tuesday, November 6, 2012 at 12:00 PM
10:30 AM
10:30 AM – 11:00 AM
- Interviewee: Dr. Daniel Sürder and Dr. Roberto Corti
- Topic: Results of the Swiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction (Swiss AMI) Trial
- Embargo lift: Tuesday, November 6, 2012
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Renato Lopes
- Topic: AHA Wrap-Up in Portuguese
1:30 PM
1:30 PM - 2:00 PM
- Interviewee: Dr. Massimo Mancone
- Topic: AHA Wrap-Up in Italian
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Basil Lewis
- Topic: AHA Wrap-Up in Hebrew
2:30 PM
2:30 PM – 3:00 PM
- Interviewee: Dr. Anne B. Curtis
- Topic: Biventricular versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block (BLOCK HF Study)
- Embargo lift: Tuesday, November 6, 2012 at 4:17 PM
3:00 PM
3:00 PM – 3:30 PM
- Interviewee: Dr. Roberto Bolli
- Topic: Effect of Cardiac Stem Cells in Patients with Ischemic Cardiomyopathy: Interim Results of the SCIPIO Trial Up to 2 Years After Therapy
- Embargo lift: Tuesday, November 6, 2012 at 11:30 AM
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Harvey White
- Topic: AHA Wrap-Up from a Pacific Rim Perspective
4:00 PM
4:00 PM – 4:30 PM
- Interviewee: Dr. Howard D. Sesso
- Topic: A Randomized Trial of a Multivitamin in the Prevention of Cardiovascular Disease in Men: The Physicians’ Health Study II
- Embargo lift: Monday, November 5, 2012
4:30 PM
4:30 PM - 5:00 PM
- Interviewee: Dr. Freek W.A. Verheugt, Dr. Jan Hein Cornel, and Dr. Ton Oude Ophuis
- Topic: AHA Wrap-up from a Dutch Perspective
5:30 PM
5:30 PM - 6:00 PM
- Interviewee: Dr. Lars Wallentin
- Topic: AHA Wrap-up from a Scandinavian Perspective
Tuesday November 6, 2012
8:30 AM
8:30 AM - 9:00 AM
- Interviewee: Dr. Paul Armstrong
- Topic: AHA Wrap-Up from a Canadian Perspective
9:00 AM
9:00 AM – 9:30 AM
- Interviewee: Dr. Thomas R. Porter
- Topic: Prospective Evaluation of Outcomes With Stress Perfusion Imaging Versus Stress Wall Motion Imaging During Dobutamine or Exercise Echocardiography
- Embargo lift: Sunday, November 4, 2012
9:30 AM
9:30 AM – 10:00 AM
- Interviewee: Dr. Gregory G. Schwartz
- Topic: Effects of the Cholesteryl Ester Transfer Protein Inhibitor Dalcetrapib in Patients with Recent Acute Coronary Syndrome
- Embargo lift: Monday, November 5, 2012 at 12:00 PM
10:00 AM
10:00 AM – 10:30 AM
- Interviewee: Dr. Frederick J. Raal
- Topic: Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD): Interim Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
- Embargo lift: Monday, November 5, 2012
1:00 PM
1:00 PM - 1:30 PM
- Interviewee: Dr. Hisao Ogawa
- Topic: AHA Wrap-Up in Japanese
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Christoph Varenhorst
- Topic: AHA Wrap-Up from a Scandinavian Perspective
4:30 PM
4:30 PM – 5:00 PM
- Interviewee: Dr. Gilles Montalescot
- Topic 1: A Randomized Trial of Bedside Platelet Function Monitoring to Adjust Antiplatelet Therapy Versus Standard of Care in Patients Undergoing Drug Eluting Stent Implantation: The ARCTIC Study
- Embargo lift: Sunday, November 4, 2012
- Topic 2: AHA Wrap-Up in French